Retina

Latest News

ONYX trial results: Combo therapy gives no added benefit when treating nAMD
ONYX trial results: Combo therapy gives no added benefit when treating nAMD

February 8th 2023

The trial showed no added benefit of nesvacumab and aflibercept combination therapy over aflibercept monotherapy.

Surprising findings from the DRCR Retina Network Protocol AA
Surprising findings from the DRCR Retina Network Protocol AA

January 23rd 2023

Geographic atrophy: What to know and why
Geographic atrophy: What to know and why

December 26th 2022

Case report: Not all multiple sclerosis is equal
Case report: Not all multiple sclerosis is equal

December 20th 2022

Have a patient with diabetes? Get the whole story
Have a patient with diabetes? Get the whole story

November 24th 2022

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.